The IPO Buzz: Pops, Flops and the Home Front

Last week was not a banner one for IPOs. Twelve companies went public with mixed results. Four IPOs finished their opening day as winners, six as losers and the other two were unchanged. The bio-IPO sector gave us a couple of noteworthy pops and flops. Their performance should not have surprised anyone. It was all right there in their respective prospectuses.
 
July 28, 2013 Read More

The IPO Buzz: Cover Story

 
Last week’s best-performing IPO, OncoMed Pharmaceuticals (OMED ), started trading 65.6 percent above its initial offering price. This should not have come as a surprise. The clue to this biotech IPO’s winning performance can be found on the cover of its prospectus. This week’s calendar has a few more IPOs sending the same signal. All you have to do is look.
 
July 21, 2013 Read More

The IPO Buzz: Summer Storm

 
The IPO market exploded out of the U.S. Securities and Exchange Commission’s filing window with the fury of a summer storm. Starting last Monday, five companies filed plans to go public, 15 companies updated their previous filings and 14 IPOs hit the calendar. That’s not bad for the dog days of summer.
 
July 14, 2013 Read More
Page 16 of 90« First...10...1415161718...304050...Last »